British / Swedish drugmaker AstraZeneca has announced promising results in developing a vaccine. An early analysis of some of its late-stage clinical trials, conducted in the UK and Brazil, showed that its coronavirus vaccine was 70.4 percent effective in preventing Covid-19, suggesting that the world could eventually have at least three working vaccines - and greater supply - to help curb the pandemic. However, doubts are being expressed about the results of the trials, mainly because they are based on a very small sample of people. British scientists are defending the validity of the findings, and look forward to further evidence becoming available in December. See
Covid-19 vaccines
Written by David Fletcher 26 Nov 2020Additional Info
- Pray: for God’s anointing of wisdom and perception to be poured over the scientists, NHS, researchers, and all fighting the Covid battle with research and development. (Isaiah 11:2)
- More: www.nytimes.com/live/2020/11/23/world/covid-19-coronavirus
Tagged under